CVET Covetrus Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CVET

Price (delayed)

$29.92

Market cap

$4.08B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.22

Enterprise value

$4.85B

Sector: Healthcare
Industry: Health Information Services

Highlights

The company's equity rose by 23% YoY and by 9% QoQ
The debt has contracted by 10% YoY and by 5% from the previous quarter
Covetrus's EPS has plunged by 100% from the previous quarter but it has soared by 98% YoY
The net income has soared by 98% YoY but it has shrunk by 58% QoQ
CVET's gross margin is down by 2.1% year-on-year

Key stats

What are the main financial stats of CVET
Market
Shares outstanding
136.23M
Market cap
$4.08B
Enterprise value
$4.85B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.48
Price to sales (P/S)
0.81
EV/EBIT
231.18
EV/EBITDA
23.01
EV/Sales
1.12
Earnings
Revenue
$4.34B
EBIT
$21M
EBITDA
$211M
Free cash flow
-$1M
Per share
EPS
-$0.22
Free cash flow per share
-$0.01
Book value per share
$12.05
Revenue per share
$36.77
TBVPS
$14.86
Balance sheet
Total assets
$3.5B
Total liabilities
$1.92B
Debt
$1.07B
Equity
$1.54B
Working capital
$740M
Liquidity
Debt to equity
0.7
Current ratio
2.07
Quick ratio
1.25
Net debt/EBITDA
3.69
Margins
EBITDA margin
4.9%
Gross margin
18.4%
Net margin
-0.4%
Operating margin
-1.6%
Efficiency
Return on assets
-0.5%
Return on equity
-1.4%
Return on invested capital
1.1%
Return on capital employed
0.7%
Return on sales
0.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CVET stock price

How has the Covetrus stock price performed over time
Intraday
1.6%
1 week
2.43%
1 month
-4.35%
1 year
277.78%
YTD
4.11%
QTD
-0.17%

Financial performance

How have Covetrus's revenue and profit performed over time
Revenue
$4.34B
Gross profit
$798M
Operating income
-$69M
Net income
-$19M
Gross margin
18.4%
Net margin
-0.4%
The net income has soared by 98% YoY but it has shrunk by 58% QoQ
The net margin has soared by 98% YoY but it has contracted by 33% from the previous quarter
Covetrus's operating margin has surged by 94% YoY and by 11% QoQ
CVET's operating income has soared by 93% year-on-year and by 9% since the previous quarter

Growth

What is Covetrus's growth rate over time

Valuation

What is Covetrus stock price valuation
P/E
N/A
P/B
2.48
P/S
0.81
EV/EBIT
231.18
EV/EBITDA
23.01
EV/Sales
1.12
Covetrus's EPS has plunged by 100% from the previous quarter but it has soared by 98% YoY
The P/B is 44% above the last 4 quarters average of 1.7
The company's equity rose by 23% YoY and by 9% QoQ
The P/S is 60% more than the last 4 quarters average of 0.5
Covetrus's revenue has increased by 9% YoY and by 2.7% from the previous quarter

Efficiency

How efficient is Covetrus business performance
The company's return on invested capital has surged by 175% QoQ and by 102% YoY
Covetrus's ROS has soared by 150% from the previous quarter and by 102% YoY
The ROA has soared by 98% YoY but it has plunged by 67% from the previous quarter
The return on equity has surged by 97% year-on-year but it has dropped by 56% since the previous quarter

Dividends

What is CVET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CVET.

Financial health

How did Covetrus financials performed over time
CVET's total assets is 82% greater than its total liabilities
CVET's quick ratio has soared by 67% year-on-year but it is down by 2.3% since the previous quarter
The current ratio has grown by 28% year-on-year
The debt is 30% less than the equity
The debt to equity has declined by 26% year-on-year and by 13% since the previous quarter
The company's equity rose by 23% YoY and by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.